Credit: Scripps Research Institute California

For the first time, chemists have completed an enantioselective total synthesis of the complex natural product (+)-phorbol. And they did it with a route that requires only 19 steps. That’s a dramatic cut in chemical transformations from previous approaches, which took 40 to 52 steps to make a racemic mixture of the compound.

Since its discovery more than 80 years ago, densely functionalized, polycyclic phorbol has intrigued both chemists and biologists. One source of phorbol is the sap of the manchineel tree, native to the Caribbean. The sap can cause skin to blister on contact. Certain derivatives, known as phorbol esters, encourage tumors to grow rapidly. But compounds in the phorbol family have also shown promise as immune-modulating, antiviral, and anticancer therapies.

Phorbol and its derivatives are frequently made via semisynthesis, where a compound with much of phorbol’s skeleton is extracted from a natural source and then synthetically transformed. But this approach makes it impossible to make certain phorbol analogs. Seeking access to those compounds, Phil S. Baran, Shuhei Kawamura, and Hang Chu of Scripps Research Institute California and Jakob Felding of LEO Pharma developed a new enantioselective synthesis of phorbol (Nature 2016, DOI: 10.1038/nature17153).

Baran, who led the project, notes that strategy was the key to this synthesis, as opposed to cutting-edge chemistry. “Everything that’s in this paper could have been done in 1978,” he says. The crucial insight, Baran notes, was to recognize that a key intermediate his group had previously used to make the anticancer compound ingenol could be diverted to make phorbol—much like what happens biosynthetically.

Sign up for C&EN's must-read weekly newsletter Email Address * Subscribe » Contact us to opt out anytime